Skip to main content
DIRUI INDUSTRIAL CO.,LTD. logo

DIRUI INDUSTRIAL CO.,LTD. — Investor Relations & Filings

Ticker · 300396 ISIN · CNE100001XS7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,689 across all filing types
Latest filing 2020-11-17 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300396

About DIRUI INDUSTRIAL CO.,LTD.

https://www.dirui.com.cn

DIRUI INDUSTRIAL CO.,LTD. specializes in the research, development, manufacturing, and distribution of medical laboratory instruments and diagnostic reagents. The company provides comprehensive solutions for in-vitro diagnostics (IVD), focusing on several key clinical areas including urinalysis, biochemistry, hematology, and chemiluminescence immunoassay. Its product portfolio features high-throughput automated analyzers and integrated laboratory systems designed to enhance diagnostic efficiency and accuracy. DIRUI serves a global market, providing medical institutions and laboratories with a wide range of diagnostic tools, from urine sediment analysis to vaginal secretion testing. The company emphasizes technological innovation and quality control to support clinical decision-making and patient care through reliable laboratory automation and standardized testing protocols.

Recent filings

Filing Released Lang Actions
关于深圳证券交易所同意公司撤回向不特定对象发行可转换公司债券申请文件的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the withdrawal of an application to issue convertible bonds to unspecified investors. It mentions approval from the Shenzhen Stock Exchange and details about the board meeting where the decision was made. The content focuses on capital raising activities and the withdrawal of a financing application, not on financial results or detailed financial statements. The document length is short (793 characters), and it is clearly an update on financing activities rather than a full report or regulatory filing. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2020-11-17 Chinese
2020年第三次临时股东大会的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the convening, procedures, and legality of a specific shareholders' meeting (the 2020 third extraordinary general meeting) of a company. It details the meeting's notice, attendance, voting procedures, and results, and concludes with a legal opinion on the meeting's compliance with laws and company regulations. It is not a financial report, earnings release, or management discussion. It is not a proxy solicitation or voting results announcement per se, but a legal opinion related to the shareholders' meeting. Given the nature of the document as a legal opinion on the shareholders' meeting, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory or compliance documents that do not fit other specific categories.
2020-11-16 Chinese
2020年第三次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an announcement of the resolutions from the 2020 third extraordinary general meeting of shareholders of Dirui Medical Technology Co., Ltd. It details the meeting date, voting procedures, attendance, voting results, and legal opinions on the meeting's validity. It does not contain financial statements or detailed financial analysis but focuses on the voting results and meeting procedures. The document length is short (1899 characters) and is clearly a formal announcement of shareholder meeting resolutions and voting outcomes. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2020-11-16 Chinese
第四届董事会第十二次临时会议决议公告
Capital/Financing Update Classification · 95% confidence The document is a formal announcement of a board meeting resolution by the company 迪瑞医疗科技股份有限公司. It details the decision to terminate the issuance of convertible bonds and withdraw the related application. The text includes meeting attendance, voting results, and references to compliance with company law and articles of association. There are no financial statements or detailed financial data presented, nor is this a report or presentation. The document is an official announcement of a board decision, specifically about a capital financing activity (termination of convertible bond issuance). Therefore, it fits best under Capital/Financing Update (CAP). The document length is short and focused on a specific board resolution related to financing, not a full report or regulatory filing.
2020-11-15 Chinese
第四届监事会第四次临时会议决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of a resolution passed at a supervisory board meeting of Dirui Medical Technology Co., Ltd. It details the decision to terminate the issuance of convertible bonds and withdraw the application related to that issuance. The document includes meeting details, voting results, and references a more detailed announcement on an external website. The document length is short (828 characters), and it primarily serves as a meeting resolution announcement rather than a full financial report or detailed filing. It does not contain financial statements or detailed financial data. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-11-15 Chinese
关于终止向不特定对象发行可转换公司债券事项并撤回申请文件的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from a company regarding the termination of a planned convertible bond issuance and the withdrawal of the related application. It details board and supervisory meetings, shareholder authorizations, and regulatory interactions with the Shenzhen Stock Exchange. The content focuses on a capital market activity (termination of convertible bond issuance) and the withdrawal of the application documents. It does not contain financial statements or detailed financial data, nor is it a report or presentation. The document is a formal announcement about a financing activity and withdrawal of application, fitting the category of Capital/Financing Update (CAP). The document length is under 5,000 characters and is a full announcement, not just a notice of report publication or certification, so it is not RPA or RNS. Therefore, the best classification is CAP with high confidence.
2020-11-15 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.